Focus Partners Wealth

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1542153 ST LOUIS, MO

Position in TEVA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,204,772

+$168,765 QoQ

Shares Held

35,560

+3.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#318

of 671 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 55% Shared 0% None 45%

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $57,760,663 across 23 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	77,994	$13,145,108
2	ZTS	Zoetis Inc.	180,366	$12,961,100
3	TAK	Takeda Pharmaceutical Co Ltd	679,950	$10,899,598
4	LNTH	Lantheus Holdings, Inc.	67,843	$7,526,502
5	UTHR	UNITED THERAPEUTICS Corp	6,078	$3,293,242
6	ALKS	Alkermes plc.	41,596	$2,179,630
7	HLN	Haleon plc	221,287	$2,064,607
8	TEVA	Teva Pharmaceutical Industries Ltd This page	35,560	$1,204,772

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,204,772	35,560	+3.4%	Shares	Sole	2026-08-12
2026-03-31	$1,036,007	34,396	-94.2%	Shares	Sole	2026-05-15
2025-12-31	$18,611,428	596,329	-3.2%	Shares	Sole	2026-02-13
2025-09-30	$12,437,887	615,737	+1058.0%	Shares	Sole	2025-11-14
2025-06-30	$891,196	53,174	+32.7%	Shares	Sole	2025-08-14
2025-03-31	$615,937	40,074	+4.5%	Shares	Sole	2025-05-20
2024-12-31	$844,903	38,335	+8.7%	Shares	Sole	2025-05-20
2024-09-30	$635,457	35,264	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.